## LDOS: Leidos Holdings, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 -3.2% below STRENGTH zone (4.0-10.0%); PEG 2.34 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($180.06)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 7, Bearish: 0)

**1. Russell Investments Group Ltd. Sells 94,434 Shares of Leidos Holdings, Inc. $LDOS**
- Source: MarketBeat | 20251202T110439 | Somewhat-Bullish | Relevance: 100%
- Russell Investments Group Ltd. significantly reduced its stake in Leidos Holdings, Inc. by selling 94,434 shares, retaining 130,182 shares valued at $20.54 million. Leidos (NYSE:LDOS) reported strong Q2 earnings, beating expectations, and raised its quarterly dividend while maintaining a "Moderate Buy" consensus rating from analysts. Insider selling and institutional ownership details are also highlighted.

**2. Leidos (NYSE: LDOS) B220-HT ETD secures G1 Standard for EU airport checkpoints**
- Source: Stock Titan | 20251202T080000 | Bullish | Relevance: 100%
- Leidos' B220-HT explosive trace detection (ETD) system has achieved G1 Standard certification, meeting a new European Civil Aviation Conference (ECAC) mandate that takes effect in late 2026 for EU airport passenger screening checkpoints. This certification ensures compliance for over 750 B220-HT units already deployed in Europe, allowing Leidos to implement necessary software updates without hardware replacement. The B220-HT system efficiently detects a wide range of explosives and narcotics, reinforcing Leidos' commitment to global security standards.

**3. Wall Street Analysts Think Leidos (LDOS) Is a Good Investment: Is It?**
- Source: Finviz | 20251201T093000 | Bullish | Relevance: 100%
- This article examines the reliability of Wall Street analyst recommendations for Leidos (LDOS) and contrasts them with the Zacks Rank. While Leidos has an average brokerage recommendation (ABR) suggesting a "Buy," the article cautions against relying solely on ABR due to potential analyst bias. It emphasizes the Zacks Rank, which is based on earnings estimate revisions, as a more reliable indicator for near-term stock price performance.

**4. Leidos (NYSE:LDOS) Upgraded at Wall Street Zen**
- Source: MarketBeat | 20251201T084927 | Bullish | Relevance: 100%
- Wall Street Zen upgraded Leidos (NYSE:LDOS) from a "buy" to a "strong-buy" rating. The company reported strong quarterly earnings, beating analyst expectations, and set a positive FY2025 guidance. Several other analysts have also recently adjusted their ratings and price targets for Leidos.

**5. Panagora Asset Management Inc. Sells 325,289 Shares of Leidos Holdings, Inc. $LDOS**
- Source: MarketBeat | 20251203T123220 | Somewhat-Bullish | Relevance: 100%
- Panagora Asset Management Inc. significantly reduced its stake in Leidos Holdings, Inc. (NYSE:LDOS) by selling 325,289 shares, decreasing its holdings by 59.8% to 218,379 shares valued at $34.45 million. This move comes as Leidos reported strong Q2 earnings, beating consensus estimates, and increased its quarterly dividend. The company also received several analyst price target increases, maintaining a "Moderate Buy" rating with an average target price of $199.23.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-07 | B of A Securiti | $235 | $200 | +18% |
| 2025-11-05 | UBS | $216 | $209 | +3% |
| 2025-11-05 | Truist Securiti | $220 | $200 | +10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-07 | B of A Securiti | main | Buy |
| 2025-11-05 | UBS | main | Neutral |
| 2025-11-05 | Truist Securiti | reit | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 6 ($0.00M) |
| Sells | 4 ($0.03M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.7% (-0.7%)
- Blackrock Inc.: 8.5% (-3.6%)
- JPMORGAN CHASE & CO: 5.3% (+93.7%)
- State Street Corpora: 4.5% (+1.4%)
- FMR, LLC: 2.9% (+31.9%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-1.7% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +10%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 2.34 elevated, pricing in significant growth expectations. Forward P/E 15.3x stretched relative to 4% growth. Quality metrics strong (ROE 29%). Analyst sentiment positive (3 raises, avg +10%). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $23.8B |
| Beta | 0.59 |
| 52W Range | $123.62 - $205.77 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.34 |
| Forward P/E | 15.3 |
| Current P/E | 16.0 |
| YoY Growth | 4.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -1.5% to -3.2% (-1.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.2pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.15x) but short-term weakness (below SMA20). RSI neutral at 47. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.19% (CS: 21) | Weak |
| RSI_14 | 46.9 | Neutral |
| MACD Histogram | -0.37 | Bearish |
| vs SMA20 | 0.986x | Below |
| vs SMA50 | 0.989x | Below |
| vs SMA200 | 1.150x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $188.44
- **Stop Loss:** $180.06 (4.4% risk)
- **Target:** $196.82 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 113
- **Position Value:** $21,293.72
- **Portfolio %:** 21.29%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-02-17 (Est: $2.58)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.72 | $3.05 | +12.3% |
| 2025Q2 | $2.66 | $3.21 | +20.8% |
| 2025Q1 | $2.50 | $2.97 | +18.7% |
| 2024Q4 | $2.27 | $2.37 | +4.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*